BBOT

Palo Alto, United States

BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics targeting RAS and PI3K malignancies.

$200.0M raised

May 2024

Venture - Series Unknown

Top Investors

Wellington ManagementDeerfield ManagementCormorant Asset ManagementOmega FundsLongwood Fund

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has BBOT raised?

BBOT has raised $200.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2024.

Who are BBOT's investors?

BBOT's investors include Wellington Management, Deerfield Management, Cormorant Asset Management, Omega Funds, Longwood Fund.

Where is BBOT headquartered?

BBOT is headquartered in Palo Alto, United States.

What does BBOT do?

BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics targeting RAS and PI3K malignancies.

What stage is BBOT at?

BBOT is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 2, 2024.

MLA

"BBOT — Funding & Investors." VCBacked, May 2, 2024, https://www.vcbacked.co/company/bbot. Accessed June 3, 2026.

APA

VCBacked. (2024). BBOT — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/bbot

Wikipedia (cite web)

{{cite web |title=BBOT — Funding & Investors |url=https://www.vcbacked.co/company/bbot |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 2, 2024.